Skip to main content

Odefsey News

FDA Approves Odefsey (emtricitabine, rilpivirine and tenofovir alafenamide) for the Treatment of HIV-1 Infection

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar. 1, 2016-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Odefsey (emtricitabine 200...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

HIV Infection

Odefsey patient information at Drugs.com